Palantir is lobbying to preserve its £330 million, seven-year contract with NHS England, as public and political opposition intensifies. Critics are questioning how the US data analytics firm secured the showpiece deal, with mounting calls to terminate it early through a 2027 break clause.
The contract has become a flashpoint over data privacy and the role of private tech companies in public healthcare. Opponents argue the deal lacks transparency, while Palantir contends that the procurement process has been unfairly politicized.
The financial details of the agreement are significant: £330 million over seven years makes it one of the largest government contracts for the company. The break clause, exercisable in 2027, offers a potential exit for the health service.
If the contract is terminated early, it could disrupt NHS England's data integration projects and hit Palantir's European public-sector revenue. Critics worry about patient data being handled by a firm with past links to US intelligence agencies.
Palantir maintains that its technology improves patient outcomes and that the criticism is politically driven. The outcome hinges on whether the government decides to trigger the break clause or let the contract run its full term.